Products

What will AGI do for Amprolium?

This classification denotes an antiparasitic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 95CO6N199Q. European Medicines Agency schedules Amprolium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05489MIG. Amprolium generally arises in the molecular formula C14H19CLN4. The term AMPROLIUM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 no. 12 1967, list 7.) AMPROLIUM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amprolium under HS 29335995 and SITC 51576. As of Q4 2014, AMPROLIUM remains the US FDA Preferred Term for this commodity. Amprolium bears US NLM identifiers UMLS ID C0002686 and NCI Concept Code C76388. SMILES: [N]1(CC2C(NC(NC2)CCC)N)C(CCCC1)C.

How AGI delivers it

Four ways AGI delivers for Amprolium

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Amprolium, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Amprolium, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Amprolium connects

measured by

  • Active Ingredient Potencymodel
  • Assay Contentmodel
  • Compound Puritymodel
  • Particle Size Distributionmodel
  • Related Substance Impurity Levelmodel
  • Residual Solventmodel